Agilent Technologies Inc at Jefferies Global Healthcare Conference in New York Transcript
Okay. Great. We're going to kick it off. I'm Tycho Peterson from the life science team. It's my pleasure to introduce Agilent this morning.
Questions & Answers
Maybe great quarter. Why don't we start there? A lot of momentum, LDG, AMG, both nicely ahead, strong growth for CAM, diagnostics, forensics, semiconductors, pharma? I mean, you're kind of humming along on all fronts, nice margin expansion too. So maybe with that in mind, just talk about some of the messages coming out of 2Q and what gets you excited about the remainder of the year.
Yes, no problem. Thanks, Tycho, and thanks. Great to be here. So great quarter 6.3% growth. We had 130 bps year-over-year margin expansion, which was just great, and that was really fueled by our Ignite transformation, 14% EPS growth, which was well ahead of guidance. So clean beat across the board.
If
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
